CME Program

8th International Conference of the Novalis Circle

Location: Munich
Date: September 21–22, 2018

Program Description: The 8th International Conference of the Novalis Circle will highlight scientific innovation, best practices and key initiatives designed to optimize clinical outcomes in oncology by integrating stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) across multidisciplinary cancer teams.

This meeting will feature today’s foremost international experts in radiation oncology and neurosurgery sharing their perspectives on brain metastasis, primary benign tumors, vascular malformations, functional indications, spine metastasis and how new clinical paradigms offer value-based medicine and patient-centered health care.

Objectives: At the conclusion of the program, participants will be able to:

  • Evaluate radiosurgery alone as initial therapy for multiple brain mets
  • Describe the indications, risks and outcome data for spinal SRS
  • Describe the current modern management of skull based tumors
  • Review the current management of AVMs

Target Audiences: Radiation oncologists, neurosurgeons, medical physicists and other members of the radiation oncology community who are members of the Novalis Circle.

Format: Live lecture

DAY 1 - General Session
September 21, 2018
DAY 2 - General Session
September 22, 2018
DAY 2 - Physics Session
September 22, 2018

Brain Metastases

Session Chair: Douglas Kondziolka

How Research is Breaking the Rules of Brain Metastasis Patient Care (15min)

Douglas Kondziolka, New York University Langone Medical Center, New York City, USA

Benefits of Neo-Adjuvant SRS Versus En Bloc Resection

Anthony Asher, Neuroscience Institute, Atrium Health Care System, Charlotte, USA

SRS-related Complications and Long-term Maintenance of Mini-Mental State Examination Scores

Masaaki Yamamoto, Katsuta Hospital Mito GammaHouse, Hitachinaka, Japan

Clinical Implementation of Software for Treatment of Multiple Brain Metastases

Maximilian Niyazi, LMU University Hospital of Munich, Munich, Germany

Clinical Outcomes Utilizing Software for Treatment of Multiple Brain Metastases

Prabhakar Tripuraneni, Scripps M.D. Anderson Cancer Center, La Jolla, USA

Break (30min)

Next Technological Iteration for Treatment of Multiple Brain Mets

Susanne Rogers, Kantonsspital, Aarau, Switzerland

Treatment Response Assessment and Re-treatment Decision Making

Diana Horvath-Rizea, Klinikum Stuttgart, Stuttgart, Germany

Role of Radiosurgery for Treatment of Brain Metastases in the Era of Targeted and Immunotherapies

Veronica Chiang, Yale University, New Haven, USA

Clinical Evaluation of Neurocognitive Assessment Tools

Mark de Ridder, Universitair Ziekenhuis Brussel, Brussels, Belgium

Patient Specific QA and IGRT Requirements in Single Isocenter Treatments

Nzhde Agazaryan, University of California Los Angeles, Los Angeles, USA

Poster Winner Presentation (5min)

Treatment of Multiple Brain Metastases Using Single Isocentric Technique with Forward Planned Dynamic Arcs

Deborah Jiang, Department of Radiation Oncology, Kaiser Permanente Los Angeles, Los Angeles, USA

Q&A (25min)

Panel Discussion


Session Chair: Javier Fandino

Management News for Patients with Benign Skull Base Tumors (15min)

Javier Fandino, Kantonsspital, Aarau, Switzerland

Improved Intraoperative Visualizations to Enhance Extent of Resection

Orin Bloch, Northwestern Memorial Hospital, Chicago, USA

The Role of Surgical Planning for Vestibular Schwannoma Surgery

Isaac Yang, University of California Los Angeles, Los Angeles, USA

Standardizing Radiosurgical Treatment with New Automated Software for Cranial SRS

Reinhard Wurm, Klinikum Frankfurt Oder, Frankfurt Oder, Germany

Clinical Outcomes Utilizing New Automated Software for Radiosurgical Treatment of Primary Tumors

Kenneth Usuki, University of Rochester Medical Center, Rochester, USA

Q&A (15mins)

Panel Discussion

Break (20min)


Session Chair: Yoshiya Yamada

Management News for Patients with Spinal Metastasis (15min)

Yoshiya (Josh) Yamada, Memorial Sloan Kettering Cancer Center, New York City, USA

Clinical and Technical Considerations for Post-Operative SBRT - An Emerging Paradigm Shift

Arjun Sahgal, Sunnybrook Health Sciences Centre, Toronto, Canada

Patterns of Failure and SRS Planning Volume Considerations for Patients with Metastatic Sarcoma

Amol Ghia, University of Texas M.D. Anderson Cancer Center, Houston, USA

Starting a Radiosurgical Program and Benefits of Modern Software Tools

Filippo Alongi, Ospedale Sacro Cuore- Don Calabria, Negrar, Italy

Poster Winner Presentation (5min)

Intensity-Modulated Stereotactic Radiotherapy for Intramedullary Cervical Spinal Metastases: Report of 2 Cases

Yoshimasa Mori, Shin-Yurigaoka General Hospital, Kawasaki, Japan

Q&A (25min)

Panel Discussion


Session Chair: Reinhard Wurm

Management News for Patients with AVMs (15mins)

Reinhard Wurm, Klinikum Frankfurt Oder, Germany

The Role of Focal Therapy for ARUBA-Eligible Patients

Howard Riina, New York University Langone Medical Center. New York City, USA

AVM Nidus Definition via Planar DSA Co-Registration with MRI-based Maximum Intensity Projections

Mohsen Javadpour, Beaumont Hospital, Dublin, Ireland

Hypo-Fractionated Stereotactic Radiosurgery Management of Large Arteriovenous Malformations

Jan Boström, University Hospital of Bonn (UKB), Bonn, Germany

Poster Winner Presentation (5min)

Validation of Smartbrush Angio Registration for Frameless Stereotactic Targeting of Brain AVM

Ingrid Kuijper, Amsterdam UMC, Amsterdam, Netherlands

Q&A (10min)

Panel Discussion

Break (15min)


Session Chair: Antonio DeSalles

Management News for Patients with Functional Disorders (15min)

Antonio DeSalles, Hospital do Coracao (HCor), University of California Los Angeles, Sao Paolo, Brazil

Benefits of Data Enrichment Solutions for Gamma Knife Radiosurgery Planning

Selcuk Peker, Koc University, Istanbul, Turkey

Effects of MRI Distortions for Target Definitions in Functional Treatments

Thierry Gevaert, Universitair Ziekenhuis Brussel, Brussels, Belgium

Expanding Novalis Radiosurgery Applications for Functional Indications

Michael Dally, ICON Cancer Centre, Epworth Hospital, Melbourne, Australia

Radiosurgery Registry Data Mining: Process and Results from the First 3000 Patients

Douglas Kondziolka, New York University Langone Medical Center, New York City, USA

How Machine Learning Can Improve Medical Outcomes

Eric Oermann, Mount Sinai School of Medicine, New York City, USA

Poster Winner Presentation (5mins)

Evaluation of Elements Anatomical Mapping for OAR Contouring

Olaf Wittenstein, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany

Q&A (20mins)

Panel Discussion


Session Chair: Timothy Solberg

Complex Multifocal Planning and IGRS Requirements

Manuel Todorovic, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

Dosimetric Comparison of Two Planning Software Applications for Treatment of Brain Metastases

Marie-Claude Biston, Centre Léon Bérard, Lyon, France

MLC Leakage Analysis for Quality Assurance

Charles Geraghty, Anne Arundel Medical Center, Annapolis, USA

ExacTrac Frameless Radiosurgery Clinical Validation for Functional Radiosurgery Patients

Thierry Gevaert, Universitair Ziekenhuis Brussel, Brussels, Belgium

Frameless Radiosurgery Accuracy for Elekta Configurations

Philipp Freislederer, LMU University Hospital of Munich, Munich, Germany

Break (15min)

Dosimetric Evaluation of New Automated Planning Tools for Spine SRS

Niko Papanikolaou, Mays Cancer Center - UT Health San Antonio, MD Anderson Cancer Center, San Antonio, USA

Clinical Implementation and Quality Assurance for Spine Radiosurgery

Daniel Venencia, Instituto Zunino - Fundacion Marie Curie, Cordoba, Argentina

The Means for Radiosurgery Quality Management: Novalis Certified

Timothy Solberg, University of California San Francisco, San Francisco, USA

E-Poster Winner Presentation (5min) Comparison of Linac-Based Single Isocenter Dynamic Conformal Arc Software to Cobalt-Based Multiple Isocenter Planning Software

Michel Chea, Radiation Oncology Department, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

Q&A (30min)

Panel Discussion

Sponsored by:

Supported by an educational grant from: Brainlab AG

DISCLOSURE POLICY: The Institute for Medical Education (IME) adheres to all IMQ/CMA/ACCME Essential Areas, Standards and Policies. It is IME’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that IME may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

ACCREDITATION STATEMENT: The Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT: The Institute for Medical Education designates this live activity for a maximum of designates this live activity for a maximum of 13 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This meeting has applied to ABR for self-assessment continuing medical education credits toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program. *Will be defined once the agenda is finalized

In accordance with the ACCME’s revised Standards of Commercial Support, potential conflicts of interest are thoroughly vetted by the Executive Committee of IME. All conflicts are resolved prior to the beginning of the activity by the IME peer review process. The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of IME.

Provider approved by the California Board of Registered Nursing, provider number 10672 for a maximum of 12.5 contact hour(s).

CULTURAL AND LINGUISTIC COMPETENCY: California Assembly Bill 1195 requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency.  The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area. The Institute for Medical Education Resources for Physicians also contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws. You are encouraged to visit the portal: